Led · Equity · Apr 2024

Hexigone Inhibitors develops a patented Intelli-ion technology designed to sit within protective coatings and activate only when corrosion begins, working at low dosages compared with traditional inhibitors. The company positions the approach for use by coatings manufacturers and for dual-use applications across defence, marine and heavy industry, aiming to lower material costs, reduce carbon intensity in coatings manufacturing, and decrease dependence on legacy heavy-metal chemistries. Hexigone claims the technology offers environmental benefits through reduced toxic inhibitor use and support for circular-economy manufacturing. The company is pursuing commercial deployment, international scale-up and the development of manufacturing capabilities, and has public-sector relevance highlighted by Ministry of Defence support through UKI2S. Financially, Hexigone has secured a £1.2m seed package combining UKI2S equity, angel investment and an Innovate UK grant, and is seeking an additional £300,000–£500,000 to accelerate growth.